
Elziverine
CAS No. 95520-81-3
Elziverine( —— )
Catalog No. M36165 CAS No. 95520-81-3
Elziverine is an orally available small molecule calmodulin antagonist.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 426 | Get Quote |
![]() ![]() |
5MG | 655 | Get Quote |
![]() ![]() |
10MG | 934 | Get Quote |
![]() ![]() |
25MG | 1343 | Get Quote |
![]() ![]() |
50MG | 1812 | Get Quote |
![]() ![]() |
100MG | 2385 | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameElziverine
-
NoteResearch use only, not for human use.
-
Brief DescriptionElziverine is an orally available small molecule calmodulin antagonist.
-
DescriptionElziverine is an orally available small molecule calmodulin antagonist.Elziverine in vitro treatment inhibited Ca-loading-induced acanthocyte formation in SHRSP, WKY, and Wistar rats in a concentration-dependent manner.Elziverine can be used for the treatment of neurological disorders, and may be used for the study of cognitive disorders.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayEndocrinology/Hormones
-
TargetCaMK
-
RecptorCaMK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number95520-81-3
-
Formula Weight543.65
-
Molecular FormulaC32H37N3O5
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(C=1C2=C(C(CN3CCN(CC3)C4=C(OC)C=CC=C4)=CN1)C=C(OC)C(OC)=C2)C5=CC(OC)=C(OC)C=C5
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog



related products
-
Perphenazine
Perphenazine is a typical antipsychotic drug, inhibits 5-HT2A receptor (5-HT2A), Alpha-1A adrenergic receptor (α1A), Dopamine receptor D2/D3, D2L receptor, and Histamine H1 receptor (H1).
-
Prochlorperazine
An antipsychotic phenothiazine derivative with actions and uses similar to those of CHLORPROMAZINE.
-
p-Hydroxy-cinnamic a...
p-Hydroxycinnamic acid can inhibit platelet activity, with IC50s of 371 μM, 126 μM for thromboxane B2 production and lipopolysaccharide-induced prostaglandin E2 generation, respectively.